NeuralCure AI launches the first Diagnostic & Digital Twin OS, reshaping patient-led preventative healthcare with AI-driven infrastructure.
![]() |
NeuralCure AI unveils its cutting-edge OS for preventative and regenerative care clinics, offering intelligent infrastructure for patient-powered health systems. Image: NeuralCure AI |
DENVER, USA — June 19, 2025:
NeuralCure AI, Inc. on Thursday announced the launch of its pioneering Diagnostic & Digital Twin Operating System, the first platform purpose-built to support the fast-growing field of preventative, regenerative, and patient-led healthcare. The announcement comes as public confidence in traditional healthcare models continues to wane, giving rise to a \$600 billion+ market driven by patients seeking autonomy, intelligence, and transparency in their care.
With this launch, NeuralCure AI positions itself as the technological backbone of a new healthcare era. The platform integrates clinical-grade AI diagnostics, real-time digital twin simulations, and a unified data aggregation system capable of syncing lab results, wearables, environmental data, and more. This infrastructure is tailored to support modern clinics operating outside of insurance-based systems and built around cash-pay, early detection, and personalized treatment models.
“This market is happening with or without the old system, and there's no putting the cat back in the bag,” said Orin Wilson, CEO of NeuralCure AI. “Patients are leading the charge. NeuralCure is the infrastructure that ensures this revolution actually works.”
Amid declining trust in institutional healthcare—driven by pandemic-era missteps, pharmaceutical skepticism, and the complexities of insurance—patients are no longer passive recipients of care. They are proactively ordering their own labs, using AI to interpret symptoms, and seeking out clinics that align with their values. NeuralCure’s platform addresses this shift by empowering both patients and clinics with smarter tools for decision-making and preventative care planning.
John Glenn, Head of Product at NeuralCure AI, compared the platform’s significance to a foundational shift. “Just like Stripe built the OS for internet commerce, we’re building the Diagnostic & Digital Twin OS for patient-powered care. Everyone else is building tools—we’re building the layer those tools plug into.”
With early adoption already underway among clinics focused on longevity, regenerative medicine, and functional health, NeuralCure AI is quickly becoming the go-to infrastructure partner for next-generation care providers. Backed by Forum Ventures and Bad Ventures, the company is poised to help scale the future of healthcare—one built not around bureaucracy, but around patient empowerment.